Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis

The most common bone disease in humans is osteoporosis (OP). Current therapeutics targeting OP have several negative side effects. Bone morphogenetic protein 2 (BMP2) is a potent growth factor that is known to activate both osteoblasts and osteoclasts. It completes these actions through both SMAD-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Durbano, Hilary W., Halloran, Daniel, Nguyen, John, Stone, Victoria, McTague, Sean, Eskander, Mark, Nohe, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555210/
https://www.ncbi.nlm.nih.gov/pubmed/32967078
http://dx.doi.org/10.3390/ijms21186909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555210/
https://www.ncbi.nlm.nih.gov/pubmed/32967078
http://dx.doi.org/10.3390/ijms21186909

Ejemplares similares